Search

everythinglearnresearchcommunity

for

Search:↓

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

pCLCA2 protein may help maintain skin structure and function.

A boy with Pachyonychia congenita has a confirmed gene mutation, highlighting the need for a local genetic database in India.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Dab2 protein is crucial for hair follicle stem cell renewal and preventing early aging.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Genetic variants in specific genes cause a type of hair loss.

Plakophilin 1 helps control skin cell immune responses to prevent excessive inflammation.

Cadd4 effectively reduces cholesterol levels without side effects.

Severe CCCA may be biologically and clinically different from milder forms.

A new gene mutation linked to a skin condition was found in a Spanish family.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Scientists created a cell model to study and find treatments for a skin disease called RDEB.

A PKP1 gene mutation causes skin fragility and hair loss in Chesapeake Bay retriever puppies.